This effect was confirmed in vitro using HT-29 and SW620 colorectal cancer cells, where TRIM14 knockdown increased PTEN levels and reduced AKT phosphorylation, and results of xenograft models in BALB/c nude mice showed reduced tumor growth following TRIM14 silencing. Here, AKT1 is linked to colorectal cancer.